Payspan promotes Rob Pinataro to CEO and appoints Mark Chapman as President and CFO
Payspan, a Florida-based company that offers healthcare reimbursement and secured payment systems, has appointed Rob Pinataro as the CEO of the company. Pinataro had been serving as the COO of Payspan before. Payspan has also named Mark Chapman as the new president and CFO.
“As COO, it was rewarding to be a part of a team simplifying financial transactions in a healthcare landscape. Now as CEO, I look forward to accelerating our pace of innovation to help customers increase revenue, improve member engagement, and reduce administrative costs through our focus on healthcare payments,” says the newly-appointed CEO, who initially joined Payspan in 2015.
During his tenure as the COO of Payspan for three years, Pinataro led the company’s execution of growth and expansion strategies. His used his educational background, which includes Lean Six Sigma Black Belt certification, and 30 years of experience taking on progressive responsibilities for Fortune 500 and private equity-backed companies to enhance the company’s productivity.
Chapman, who joins Payspan with his 25 years of C-level and upper management experience, will be leading the sales, marketing, finance, customer service, legal and administrative activities of the company. He will also be responsible for driving revenue growth of the firm. Before Payspan, Chapman has worked with Primus Capital and has also served VoApps as its CEO and Vendormate, Inc. as its CFO. During his different roles, Chapman has managed to raise over $500 million in buy-out, equity, debt and mezzanine financing for his companies.
Speaking about his new role, Chapman, says, “Payspan has tremendous growth opportunities in a healthcare market in need of electronic enablement. I am excited to join a highly driven team at Payspan, whose members are passionate about leveraging the company’s healthcare payment automation platform to deliver innovative solutions to help health plans and providers create efficiencies, reduce costs and drive better patient outcomes.”